Literature DB >> 7028634

The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate.

D Greenwood, R C Slack.   

Abstract

The antibacterial activity of hexamine and two of its organic acid salts was compared by continuous turbidimetric monitoring of static cultures exposed to the drugs and in an in vitro model of the treatment of bacterial cystitis. At pH 5.5, concentrations of 32 to 125 mg hexamine per 1 caused some inhibition of bacterial growth, but 250 to 500 mg/l were needed to suppress growth overnight. Hexamine hippurate was found to be less active than hexamine itself, whereas hexamine mandelate was as active as the parent compound. The antibacterial effect was not inoculum dependent over the range 10(6) to 10(8) bacteria per ml, but the activity observed in pooled urine was rather less than that found in broth at the same pH. When a dense bacterial culture was exposed to changing concentrations of hexamine compounds in the bladder model, a 1 g dose infused over a 12-hour period suppressed bacterial growth for 16 to 20 hours. No systematic difference was found in the activity of the three hexamine compounds, but a similar effect was achieved by a very much lower concentration of ampicillin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028634     DOI: 10.1007/bf01640720

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Cranberry juice and the antibacterial action of hippuric acid.

Authors:  P T BODEL; R COTRAN; E H KASS
Journal:  J Lab Clin Med       Date:  1959-12

Review 2.  An in vitro model of the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1978-03       Impact factor: 5.790

3.  Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

4.  A twelve channel bacterial growth monitoring system.

Authors:  I P Mackintosh; F O'Grady; D Greenwood; B W Watson; T C Crichton; R Piper; A Ferrer
Journal:  Biomed Eng       Date:  1973-12

5.  Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect.

Authors:  D M Musher; D P Griffith
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.

Authors:  J G Gow
Journal:  Practitioner       Date:  1974-07

7.  Prevention of recurrent bacteriuria with continuous chemotherapy.

Authors:  R B Freeman; L Bromer; F Brancato; S I Cohen; C F Garfield; R J Griep; E J Hinman; J A Richardson; R H Thurm; C Urner; W M Smith
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

8.  Clinical pharmacology and antibacterial action of methenamine and its salts (mandelate, hippurate and sulfosalicylate).

Authors:  H Seneca; P Peer
Journal:  Med Times       Date:  1969-02

9.  Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.

Authors:  H Miller; E Phillips
Journal:  Invest Urol       Date:  1970-07
  9 in total
  4 in total

Review 1.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

2.  Dicarbon-yl(hexa-methyl-ene-1,3,5,7-tetra-mine-κN(1))(η(5)-penta-methyl-cyclo-penta-dien-yl)iron(II) tetra-fluoridoborate.

Authors:  Cyprian M M'thiruaine; Holger B Friedrich; Evans O Changamu; Manuel A Fernandes
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-16

3.  The large scale antibacterial, antifungal and anti-phage efficiency of Petamcin-A: new multicomponent preparation for skin diseases treatment.

Authors:  Mikayel Ginovyan; Andranik Keryan; Inga Bazukyan; Petros Ghazaryan; Armen Trchounian
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-05-18       Impact factor: 3.944

Review 4.  Urinary tract infection and subclinical bacteriuria in cats: A clinical update.

Authors:  Roswitha Dorsch; Svenja Teichmann-Knorrn; Heidi Sjetne Lund
Journal:  J Feline Med Surg       Date:  2019-10-10       Impact factor: 2.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.